In order to further decrease the time lapse between initial inoculation of blood culture media and the reporting of results of identification and antimicrobial susceptibility tests for microorganisms causing bacteremia, we performed a prospective study in which specially processed fluid from positive blood culture bottles from Bactec 9240 (Becton Dickinson, Cockeysville, Md.) containing aerobic media were directly inoculated into Vitek 2 system cards (bio-Mérieux, France). Organism identification and susceptibility results were compared with those obtained from cards inoculated with a standardized bacterial suspension obtained following subculture to agar; 100 consecutive positive monomicrobic blood cultures, consisting of 50 gram-negative rods and 50 gram-positive cocci, were included in the study. For gram-negative organisms, 31 of the 50 (62%) showed complete agreement with the standard method for species identification, while none of the 50 gram-positive cocci were correctly identified by the direct method. For gram-negative rods, there were 50% categorical agreements between the direct and standard methods for all drugs tested. The very major error rate was 2.4%, and the major error rate was 0.6%. The overall error rate for gram-negatives was 6.6%. Complete agreement in clinical categories of all antimicrobial agents evaluated was obtained for 19 of 50 (38%) gram-positive cocci evaluated; the overall error rate was 8.4%, with 2.8% minor errors, 2.4% major errors, and 3.2% very major errors. These findings suggest that the Vitek 2 cards inoculated directly from positive Bactec 9240 bottles do not provide acceptable bacterial identification or susceptibility testing in comparison with corresponding cards tested by a standard method.Detection of bloodstream infections is one of the most important tasks performed by the clinical microbiology laboratory. Rapid identification results and antimicrobial susceptibility tests are essential for guiding clinicians in the selection of the most appropriate treatment for patients with bloodstream infections (5, 22). There are few well-designed studies that have examined the clinical impact of rapid bacterial identification and antimicrobial susceptibility testing, and there is even less information on blood cultures. The available information suggests that early knowledge of these data may be related to lower mortality rates and could affect patient therapy, leading to reductions in health care costs for the pharmacy, laboratory, and other general charges (1,11,20,22).Many remarkable improvements have been made in an attempt to reduce the time required to identify pathogens in blood, and over the last several decades, a variety of automated systems have been developed for detecting or identifying pathogenic microorganisms as well as for determining antimicrobial susceptibility. Continuously monitoring automated blood culture systems have emerged as the new standard in blood culture technology, enabling detection of a positive blood culture within 24 h of initial incubatio...